Banner

Login Access

Registration allows you to post comments in our Blog.



Tags Cloud

Latest Comments

  • No comments yet.
We have 4 guests online

Blog For Research

Since Immugen is taking such an unorthodox approach to funding its research, we would like to take the opportunity to respond to your comments and concerns.
Jun 22
2010

The case for medical marijuana research on PTSD

Posted by: Craig R. Travis, M.D.

Tagged in: PTSD

This clip from Botany of Desire does a fantastic job of explaining how and why medical marijuana can help people suffering from post-traumatic stress disorder.

Jun 07
2010

Welcome!

Posted by: Bill Massey

Tagged in: human suffering

Welcome to Immugen’s website and blog for research. The intent of this blog is to allow the public a venue for expressing their views, scientific insights, and criticisms regarding cannabinoid research and medical use. Immugen is employing a new paradigm in pharmaceutical research: eliciting funding directly from the public and being completely transparent in the use of funds; offering a collaborative environment to exchange and submit research proposals; and more importantly, a mission to alleviate human suffering that is not guided by a pure profit motive.

Please let us know your thoughts as we value the dialogue. As CEO of Immugen, I assure you that I will read all comments and respond accordingly. In the spirit of transparency, you can contact me directly by e-mail bill.massey@immugen.com or by phone 1-760-443-3782. I look forward to your comments and suggestions.

Best regards,

Bill

B.W. Massey, Ph.D.
CEO, Immugen Pharmaceuticals, Inc.